Patient advocacy platform Baba has made its public debut with $6.5 million in seed led by General Catalyst, the company disclosed last week.
NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Baba, a Medicare- and Medicare Advantage-covered patient advocacy platform, today announced its public debut from stealth alongside more than $6.5 million ...